(19)
(11) EP 4 055 005 A1

(12)

(43) Date of publication:
14.09.2022 Bulletin 2022/37

(21) Application number: 20886165.8

(22) Date of filing: 04.11.2020
(51) International Patent Classification (IPC): 
C07C 229/36(2006.01)
A61P 35/00(2006.01)
A61K 9/08(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; A61K 9/08; C07C 227/44; A61K 9/0019; A61K 47/02; A61K 47/20; A61K 47/10; A61K 47/12; A61K 31/198
 
C-Sets:
C07C 227/44, C07C 229/42;
(86) International application number:
PCT/IB2020/060334
(87) International publication number:
WO 2021/090183 (14.05.2021 Gazette 2021/19)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.11.2019 IN 201921044683

(71) Applicant: Intas Pharmaceuticals Ltd.
Ahmedabad - 380054, Gujarat (IN)

(72) Inventors:
  • CHOKSHI, Nimitt
    Ahmedabad 382210 (IN)
  • SHAH, Rushabh
    Ahmedabad 382210 (IN)
  • GOBADE, Nagnath G
    Ahmedabad 382210 (IN)
  • UPADHYAY, Kamal Kumar
    Ahmedabad 382210 (IN)
  • GEORGE, Alex K
    Ahmedabad 382210 (IN)

(74) Representative: Intas Pharmaceuticals 
World Trade Center Moll de Barcelona, s/n Edifici Est, 6a planta
08039 Barcelona
08039 Barcelona (ES)

   


(54) LIQUID MELPHALAN COMPOSITION